Literature DB >> 342537

Growth and amino acid requirements of various strains of group B streptococci.

T W Milligan, T I Doran, D C Straus, S J Mattingly.   

Abstract

A chemically defined medium (FMC; B. Terleckyj, N. P. Willett, and G. D. Shockman, Infect. Immun. 11:649-655, 1975) was used to compare the growth and amino acid requirements of 16 strains of group B streptococci, consisting of both laboratory-passaged organisms and fresh clinical isolates from adult and neonatal infections. The 5 standard Lancefield immunizing strains of group B streptococci, 090 (Ia), H36B (Ib), A909 (Ic), 18RS21 (II), and D136C (III), had doubling times in FMC (28 to 36 min) similar to those observed in Todd-Hewitt glucose broth (24 to 30 min). Similar doubling times were obtained with 11 clinical isolates growing in Todd-Hewitt glucose broth and FMC. The optimum buffering capacity of FMC was provided by 0.06 M sodium phosphate, and 1% glucose gave maximum cell yield. The group B streptococci, with minor exceptions, were very homogeneous in their amino acid requirements under both aerobic and anaerobic growth conditions. Phenylalanine, tyrosine, tryptophan, glutamate, arginine, valine, leucine, lysine, methionine, isoleucine, cystine, and histidine were required by all 16 strains under both aerobic and anaerobic growth conditions. In addition, threonine was required by all strains under aerobic growth conditions, whereas only 9 strains required threonine under anaerobic conditions. Serine was required by only 3 type III fresh clinical isolates aerobically, but not anaerobically. A requirement for glycine varied from strain to strain, apparently influenced by the oxidation-reduction potential of the growth medium.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 342537      PMCID: PMC274851          DOI: 10.1128/jcm.7.1.28-33.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Microcapsule of type III strains of group B Streptococcus: production and morphology.

Authors:  C J Baker; D L Kasper
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

2.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

3.  Transmission of group B streptococci among parturient women and their neonates.

Authors:  C J Baker; F F Barrett
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

4.  Amino acid requirements of Streptococcus mutans and other oral streptococci.

Authors:  B Terleckyj; G D Shockman
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

5.  Growth of several cariogenic strains of oral streptococci in a chemically defined medium.

Authors:  B Terleckyj; N P Willett; G D Shockman
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

6.  Requirements for growth of Streptococcus agalactiae in a chemically defined medium.

Authors:  N P Willett; G E Morse; S A Carlisle
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

7.  Effects of nutritional characteristics of Streptococcus agalactiae on inhibition of growth by lactoperoxidase-thiocyanate-hydrogen peroxide in chemically defined culture medium.

Authors:  M N Mickelson
Journal:  Appl Environ Microbiol       Date:  1976-08       Impact factor: 4.792

8.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.

Authors:  C J Baker; D L Kasper
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

9.  Extracellular neuraminidase production by group B streptococci.

Authors:  T W Milligan; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

10.  Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus.

Authors:  C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

View more
  19 in total

1.  Pigment production by Streptococcus agalactiae in quasi-defined media.

Authors:  M Rosa-Fraile; A Sampedro; J Rodríguez-Granger; M L García-Peña; A Ruiz-Bravo; A Haïdour
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

2.  High-virulence clone of group B streptococci unable to grow at high temperatures is present in serotypes other than type III.

Authors:  Gerardo C Palacios; Maria N Gonzalez; Magdalena Beltran; Jose L Arredondo; Javier Torres; Fortino Solorzano
Journal:  Curr Microbiol       Date:  2006-12-13       Impact factor: 2.188

3.  Identification of a high-virulence clone of serotype III Streptococcus agalactiae by growth characteristics at 40 degrees C.

Authors:  S J Mattingly; J J Maurer; E K Eskew; F Cox
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

4.  Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.

Authors:  G C Palacios; E K Eskew; F Solorzano; S J Mattingly
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 5.  Minireview: Gut microbiota: the neglected endocrine organ.

Authors:  Gerard Clarke; Roman M Stilling; Paul J Kennedy; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Mol Endocrinol       Date:  2014-06-03

6.  Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.

Authors:  T W Milligan; C J Baker; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

7.  Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

Authors:  T I Doran; S J Mattingly
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  A dual fluorescence technique for visualization of Staphylococcus epidermidis biofilm using scanning confocal laser microscopy.

Authors:  B A Sanford; A W de Feijter; M H Wade; V L Thomas
Journal:  J Ind Microbiol       Date:  1996-01

9.  Comparative analysis of the localization of lipoteichoic acid in Streptococcus agalactiae and Streptococcus pyogenes.

Authors:  S J Mattingly; B P Johnston
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

10.  Identification of group B streptococcal antigen with lectin-bound polystyrene particles.

Authors:  M Slifkin; R Cumbie
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.